Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251090 | SCV000305392 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000251090 | SCV000518640 | benign | not specified | 2016-02-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001522841 | SCV001732457 | benign | Glycogen storage disease type III | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001522841 | SCV002055068 | benign | Glycogen storage disease type III | 2021-07-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000675336 | SCV003800330 | benign | not provided | 2024-10-31 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000675336 | SCV005283833 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000675336 | SCV000801002 | likely benign | not provided | 2017-03-14 | no assertion criteria provided | clinical testing |